Ben Greenfield Says Everyone Is Focused on the Wrong Thing | Ben Greenfield EP 236
In a Nutshell
Ben Greenfield outlines a large upcoming carnivore diet study for rheumatoid arthritis and IBD patients comparing a ruminant-only "lion diet," a ketogenic diet, and a standard American diet control group, funded through crowdfunding and focused on symptom improvement plus gut and autoimmune markers. He details his peptide protocols for gut repair and inflammation (KPV, BPC-157, retatrutide, tesamorelin/ipamorelin) and advanced therapies like therapeutic plasma exchange and blood filtration for mold, toxins, and rejuvenation. The discussion also covers practical carnivore implementation, histamine/sulfur sensitivities, meat sourcing, family feeding strategies, and travel-optimized morning routines with zeitgebers for circadian alignment.
These notes were generated by AI and may contain inaccuracies.
The study is officially starting in 2 weeks with participants who have a diagnosis of rheumatoid arthritis or IBD. The team is still accepting applicants. The goal is to create a larger study than previous carnivore diet research, which has typically involved only around 10 participants. A prior solid study on IBD showed everyone went into remission with just 10 people. This new research aims to expand that scope into arthritis territory.
Dr. Rob Abbott is running the study after being approached due to his experience conducting multiple studies. A significant portion was crowdfunded through GoFundMe, with additional larger donations from individuals interested in carnivore research.
Research team compensation is reasonable compared to university-led studies, which were estimated in the two to three million dollar range. The majority of costs come from lab work. A stool test costs around $700 and will be done twice. Blood work is conducted throughout the study. Participants receive keto monitors to track ketones and glucose, plus body composition scales. Total costs per participant exceed $1,000. Labs will track general markers plus those associated with inflammation and autoimmunity.
Primary outcomes focus on how much participants' lives and symptoms improve according to their own reports, as this indicates whether they feel they are healing or in remission. Lab work and stool sample data will also be analyzed for patterns related to gut barrier function and autoimmune markers.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.